The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Headline
The FBI released an alert March 20 warning of a technique used by cyber actors working on behalf of the Iranian government to conduct malicious cyber activity…
Headline
The Cybersecurity and Infrastructure Security Agency March 18 released an alert urging U.S. organizations to harden their endpoint management systems following…
Headline
The Health Sector Coordinating Council Cyber Working Group and Health-ISAC (Information Sharing and Analysis Center) will host a joint cybersecurity event July…
Headline
Stryker, a medical technology company that provides services and products for hospitals, was disrupted globally by a cyberattack, the company announced March…
Headline
The White House issued an executive order March 6 to combat cybercrimes by threat groups. The order highlights how such groups can receive willing or…
Headline
The Administration for Strategic Preparedness and Response has released a new cybersecurity module for organizations to conduct risk assessments. The free…